Trial
NCT02905994
Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
Boehringer Ingelheim
Condition
AML
Intervention
Volasertib
Why stopped
Funding Withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-04